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Introduction 23

Immune Thrombocytopenia (ITP) 24
ITP is an organ specific autoimmune disorder (1) characterised by a low platelet count. In diagnostic 25 terms, ITP is defined as a platelet count of 'less than 100 x 10 9 /L (100,000/µL)' (2). Its prevalence has 26 been examined in a number of countries and ranges from 2.64 per 100,000 patients/year in Denmark 27 to 9.5 per 100,000 in the USA. A predominant number of cases in childhood are in males with this 28 changing to middle-aged women in adulthood. The overall ratio male to female ratio is thought to be 29 1:1.9 (3i). Most cases of ITP are classed as being idiopathic but some cases are secondary to coexisting 30 conditions as mentioned in section 1.2 (4). 31
Causes of ITP 32
Numerous theories have been put forward as to the cause of ITP but a definitive answer remains 33 elusive. Definitive diagnosis of the condition is still extremely difficult and is often related to 34 numerous other factors, for example SLE, HIV infection, hepatitis C, drug induced or Helicobacter 35 pylori infection. It also means that diagnosis is therefore usually made by exclusion of other disorders 36
(3). 37
One of the major hypotheses is that ITP is characterised by increased platelet destruction either by 38 antibody mediated platelet destruction or platelet lysis due to cytotoxic T-lymphocytes (1, 4, 5) . 39 Another suggestion is 'molecular mimicry' which is defined as 'similar structures shared by molecules 40 produced by dissimilar genes' (1) . Here, by a complementary mechanism, a pathogen (such as 41
Helicobacter pylori or HIV) can induce cellular injury and release self-antigens. This generates an 42 immune response that cross-reacts with additional self-antigens which are genetically distinct. The 43 theory is that a pathogen could induce antibody production in response to antigens that cross-react 44 against various platelet glycoprotein antigens. Therefore, specific antibodies might be capable of 45 causing thrombocytopenia. This mimicry of host proteins enables the pathogens to escape host 46 surveillance (1, 6, 7) . The final major theory is that there is decreased platelet production. In healthy 47 people, when platelet production equals platelet destruction and consumption, a stable platelet count 48 will occur (8). In patients with ITP, shorter platelet lifespan is consistently seen. One explanation for 49 this is that some surface antigens that are co-expressed on platelets, megakaryocyte precursors, and 50 megakaryocytes are recognised by autoantibodies. Reduced platelet production is then assumed to 51 be due to the direct effect of antibodies on the maturation of megakaryocytes or platelet release (6, 9) . 52
Certainly ITP occurs by a number of complex processes involving multiple components of the immune 53 system. Apart from decreased platelet production, a continual 'self-antigen-stimulated' response 54 ultimately leads to a deficiency in the central and/or peripheral tolerance (failure to mount an immune 55 response to an antigen) which triggers an autoreactive lymphocyte response. Evidence suggests that 56 both environmental and genetic factors are the key to this issue (1). 57
Linking ITP to food intolerance? 58
Food intolerance has been suggested as a cause of ITP, however much of the information linking the 59 two is anecdotal. The link has been recognised and documented in a few cases as early as 1936 (10), 60 but little has been documented specifically related to ITP and food intolerance between then and now, 61 except in individual case reports (11, 12, 13) . 62
Most recently, in 2012, a case study was published in the Lancet by Achterbergh, et al. which detailed 63 the case of a 70 year old man who was admitted with vomiting, nausea and fever and found to have 64 a platelet count of 32,000 per µL. After investigation and a second admission, the causative factor 65 was determined to be the walnut, and to test this, a subsequent walnut challenge was carried out. 66
His initial platelet count was 233,000 per µL, and 4 hours after being given 100g of walnuts, he 67 developed fever, nausea and vomiting, bled from a small wound and developed large haematomas 68 around venepuncture sites. Approximately 15 hours after ingestion his platelet count had dropped to 69 4,000 per µL. Following exclusion of nuts from his diet he had no further episodes and maintained a 70 normal platelet count. Although walnuts were clearly related to the sudden drop in platelet count, 71
this remains a rare case, and is likely the result of an acute ITP episode. 72
Bacteria produce numerous metabolites, some of which are volatile, others which are semi volatile or 73 not volatile at all. These may all vary depending on the food sources available in the gut. In addition, 74
as the human body produces a steady stream of metabolic waste (ammonia, lactic acid, urea, bilirubin 75 etc.) and exotoxins (produced by the microbiota in the gut) the body carries out biotransformation in 76 the liver to remove toxins by converting them to less toxic substances which may then be excreted in 77 urine or the bile (14) . 78
It is to be expected, therefore, that these volatile organic compounds (VOCs) may be detected in urine 79
headspace. Approximately 279 VOCs have been identified in urine in apparently healthy individuals 80 (14i). Urinary VOCs for example, have been shown to discriminate tuberculosis patients from healthy 81 subjects (14ii) and some have shown differences in the female reproductive cycle during ovulation 82 (14iii). The headspace of urine of a group of ITP patients and healthy control subjects were therefore 83 studied using selected ion flow tube mass spectrometry (SIFT-MS) to look at initial overall differences 84 between urine headspace from the ITP and healthy control groups; this was then extended to seeing 85 how the urinary VOC profile was affected by diet. 86
The data were compared using univariate and multivariate statistical analysis. The aim of this project 87 was to discover if ITP subjects and healthy controls could be easily differentiated by looking at urinary 88 profiles using SIFT-MS and to determine whether food intolerance is involved in ITP. 89
Methods 90
Initial Phase: Patient recruitment 91
The initial volunteer population group for this part of the study was recruited via the ITP Support 92
Association. 93
Ethical permission for the study was obtained from the Cambridge Local Research Ethics committee 94 (LREC) reference 11/EE/0084. Patients of either sex aged 18-65 years suffering from chronic primary 95 immune thrombocytopenia were recruited. 96
The diagnosis of ITP was based on the criteria set out by Rodeghiero et al (2009) with a platelet count 97 of less than 100,000/µL, and a history of this condition for at least 12 months. Patients who had 98 undergone splenectomy were included, provided the operation was not recent and that they were 99 taking no other antibiotics than penicillin to reduce the risk of infection. Patients on other drugs were 100
included if their platelet count remained low and provided that the drug was started before the 101 longest time to peak response quoted by Rodeghiero et al., 2009 and that they were willing to 102 continue that treatment until their participation in the trial was concluded. 103
On recruitment, a urine sample was taken and was tested with a multistix® urianalysis (Siemens UK) 104 test before being frozen and sent for SIFT-MS headspace analysis. 105
A healthy control group of 50 people aged 18-65 years was also selected; these had the same initial 106 tests performed. 107
Subjects were excluded from the study according to the following criteria: 
Sampling 120
Participants were recruited from around the UK and travelled from their homes to attended 121
Addenbrooke's Hospital. Here they provided written informed consent. They were asked to complete 122 a symptom questionnaire and provided a sample of urine and blood. The urine samples were collected 123 in 20ml Fisherbrand TM scintillation vials (Fisher Scientific, Loughborough) while the subjects were 124 present at the hospital and were immediately frozen at -80°C. All samples were anonymised and 125 labelled with a specific number; the code was only known by the principal investigator (PI). Urine 126 samples were frozen for a maximum of 3 months before being thawed and immediately tested. Blood 127 was taken into Thromboexact® (Sarstedt AG & Co, Germany) containers to ensure accuracy of platelet 128 counts and was immediately transferred to the laboratory for testing. 129
Demographics 130
All initial samples were collected over a 12 month period. The mean age in years (± s.d) of the healthy 131 controls was 48.2 ± 10.9 with a percentage of female sex being 54.3%. The mean age in years (± s.d) 132
of the ITP volunteers was 47.6 ± 12.9 with the percentage female sex being 66.7%. 133
From the initial ITP results, a group of participants with the lowest platelet counts throughout the 134 whole ITP group were selected to undertake dietary modification using the elemental diet E028 extra 135 (Nutricia, Trowbridge, UK). A group of healthy controls also volunteered to limit their nutrition to 136 elemental E028 extra for 7 days. 137
Dietary modification -Elemental Diet 138
Elemental 028 Extra diet is a nutritionally complete liquid formula containing a mix of essential and 139 non-essential amino acids, a single fatty oil, minerals, maltodextrins, vitamins and trace elements. It 140 was administered in 250ml ready-made cartons in a choice of flavours. E028 Extra has been shown to 141 be of therapeutic value in Crohn's disease and refractory coeliac disease (15,16). 142
Each participant gave a blood and urine sample taken prior to beginning the diet and had a 143 consultation with a registered dietician to give advice on what the diet entailed, and what to expect. 144
They were given written details of the diet and asked to complete a symptom diary. E028 extra was 145 introduced gradually in half quantities over the first few days and then fully for the rest of the 4-week 146 period. A blood sample for platelet count was taken every week either by the patient's General 147
Practitioner (GP), or at Addenbrooke's Hospital. Urine samples were taken before the diet was started 148 and after the diet was completed and were immediately frozen at -80°C before being sent for analysis 149 by SIFT-MS. 150
Control Group -Elemental Diet 151
The healthy volunteers were people who were known to be healthy with no blood or gastrointestinal 152 disorders or food intolerances. Due to time restrictions with the project and the difficulties 153 encountered when being on the E028 Extra, only 3 members of the research team took part. As these 154 subjects had to follow their normal lives, it was not appropriate for them to continue E028 Extra for 155 the full four weeks, and they remained on it for 5-8 days. 156 A blood sample was taken prior to starting the diet and on the last day of the diet. A urine sample 157 was also taken prior to starting the diet and on the last day. Following the collection of urine samples, 158 they were frozen at -80°C before being processed using SIFT-MS. 159
Urine Sample Preparation 160
Urine samples were removed from the freezer and placed in a room temperature environment to fully 161 defrost. To 5ml of each sample, which was pipetted from the scintillation vial, 125µl of 13M 162 hydrochloric acid was added to aid in the generation of VOCs (20). Exactly 3g of sodium chloride was 163 added to the empty Nalophan sample bags (Foodpak®) that had been made up to 40cm long and 164 sealed at one end with a cable tie. The acidified urine was then added to each bag. The Nalophan 165 bag was then sealed around silicone tubing with a Swagelok® fitting, and the urine mixed by gently 166
shaking to ensure even distribution of the acid and the salt. Each sample bag was then filled with 167 hydrocarbon-free air and sealed with a Swagelok® nut. 168
The samples were placed into an incubator at 40°C. The door was sealed and then the samples were 169 left for one hour to generate headspace prior to headspace analysis by selected ion flow tube mass 170 spectrometry (SIFT-MS). 171
SIFT-MS Analysis 172
In this case a SIFT-MS MkII from PDZ Europa was used, with a flow rate through the heated capillary 173
giving a pressure of 0.008 Torr in the flow tube. Samples were analysed for T5 x 6 at unit resolution. 174
Full details of how SIFT-MS may be used to analyse trace gases and volatile organic compounds may 175 be found elsewhere (18), however, a brief explanation is warranted here. In SIFT-MS, precursor ions 176 (H3O + , NO + and O2 + ) are generated in a microwave discharge and may then be selected by a quadrupole 177 mass filter. The selected ion is then injected into a fast flowing helium carrier gas, and down a flow 178 tube. A sample is then introduced into the flow tube at a rate of 15ml/min, and the precursor ion 179 reacts with the trace gases and volatile organic compounds in the sample. Each sample is analysed 180
for 5 seconds, on 6 separate scans, giving a total of 30 seconds analysis on each scan. The precursor 181
and product ions in the carrier gas are separated in a second quadrupole mass spectrometer and 182 subsequently counted in a detector. Data may be obtained through scanning a spectrum at a user-183
defined range of mass-to-charge ratio (m/z) values and quantification is carried out using a kinetics 184 database stored in the instrument. In this case the user defined m/z range was 10-140 m/z. 185 was performed prior to the classification. The number of features in each sample following feature 206 selection via the student t test was 9. The statistical significance of the classification accuracy was 207 determined by performing permutation testing which involved randomising the class assignation 300 208 times, and for each random assignation, the two-step bootstrapping process was performed. The 209 statistical z-test was employed to determine the significance (p < 0.05) (20). 210
Statistical Analysis
Results 211
Initial Platelet count 212
Results of the platelet counts showed a highly significant difference between the ITP and the control 213 groups. Although the subject groups were relatively large, they were still assessed with non-214 parametric testing as there were fewer than 100 samples in each group and were not normally 215 distributed. 216
The data were analysed using Mann Whitney U testing. With this analysis the two sets of data were 217 found to be significantly different. The z-score was found to be -6.98 with a p-value of <0.00001. All 218 the control samples had normal platelet counts with a mean platelet count of 236,200 per µL and a 219 range of 147,000-341,000 per µL. The ITP volunteer group had a mean platelet count of 58,000 per 220 µL with a range of 5,000-281,000 per µL. 221
There were some outliers in the ITP group which were closer to normal platelet levels. These were 222 117,000, 144,000 and 281,000 per µl and although these data are included in these initial results, all 223
were subsequently excluded from the study. 224
Platelet Counts before and after E028 Diet 225
In total 10 volunteers with ITP and 3 healthy control volunteers went onto the E028 diet. Platelet 226 counts were assessed prior to and after dietary modification with the E028 diet. 227
When ITP platelet counts were assessed, no significant increase in platelet count occurred while on or 228
initially after taking the E028 diet ( Figure 1) . 229
Analysis of VOCs in Urine Headspace using SIFT-MS 230
Univariate Analysis of urine headspace of whole cohort of ITP and control participants 231
In total 35 controls and 42 ITP subjects were included in this study to compare the groups of ITP 232 participants and healthy control participants. Univariate analysis of urine headspace of the H3O + data 233 using the Mann-Whitney U test, found two m/z values to be significantly different between ITP 234 sufferers and healthy controls. These m/z values were m/z 18 and m/z 43. Using box and whisker 235 plots ( Figure 2 ) these differences are shown. These ions are likely to represent ammonia and 1 or 2 236 propanol respectively. 237
Multivariate Analysis of urine headspace of whole cohort of ITP and control participants 238
When analysing the H3O + data alone, it was found that PLS-DA in conjunction with feature selection 239 via the Student t test (STT) offered the best result when comparing the headspace of urine from ITP 240 suffers and healthy controls. Overall the percentage of correctly classified (%CC) samples was 70% 241
with a specificity of 53% and a sensitivity of 84%. The sensitivity suggests that SIFT-MS is able to show 242 there are clear differences in the volatile metabolome of subjects with ITP. However, the relatively 243 low specificity suggests that data pertaining to healthy control subjects is more complex; this could be 244 attributed to some underlying features or a wide variation in the urinary volatile metabolome of 245 healthy volunteers. The area under the ROC (AUROC) curve was calculated as 0.80. 246
In order to determine whether the overall classification value was statistically significant, permutation 247 testing was carried out (Figure 3) Of interest is that the PLS-DA loadings also showed that m/z 43 was in the opposite direction to the 255 other m/z values. This can be interpreted that ITP sufferers had strong correlations with higher counts 256 of m/z 43 using H3O + and lower counts of m/z, 34, 53, 72, 74, 76, 89 and 112 than the control subjects. 257
It also correlates with the earlier univariate analysis to show that m/z 43 is significant. 258
Combination of the abundances from all three pre-cursor ions in conjunction with the normal 259 approach of removing the precursor ions and their adducts had resulted in good performances by the 260 PLS-DA models in conjunction with feature selection by both Wilcoxon T test and Student t-test (88% 261 and 87% respectively). 262
The classification accuracy of 88% pertaining to WTT (Control versus ITP) produced a specificity of 87% 263 and a sensitivity of 89%, which is considerably better than just using H3O + alone. 264
The permutation testing demonstrated that the result was statistically significant and not due to 265
chance. Furthermore, the PLS-DA loadings (not shown) suggests that the following m/z values could 266 be influential to the distinction between ITP patients and healthy controls: 267 
Identifying the compounds related to m/z values 272
A number of m/z values have been identified above. The potential identifications indicated in table 1  273 shows potential compounds these m/z values may relate to but this would need to be verified using 274 GC/MS. 275
The m/z values for products using the O2 + precursor ion are much more difficult to identify, and 276 therefore would need another technique such as GC-MS for identification. 277
These results demonstrate that there is a clear difference between urine headspace from ITP patients 278 and healthy volunteers. 279
Dietary Modification -E028 Diet 280
Univariate Data H3O + 281
Although sample groups were small, some analysis was possible when looking at the differences that 282 the E028 diet made on the headspace analysis of both the ITP sufferers and the healthy controls. On 283 comparing the SIFT-MS data, two compounds were found to be statistically significant in the ITP group 284 of pre and post diet. These were methanol and propanol. Figure 4 and 5 illustrate the ITP group 285 results for the VOC methanol along with the corresponding control group results. Although the control 286 group was too small to be statistically compared it is illustrated that the controls showed a similar 287 pattern of reduction of methanol following E028 diet as in the ITP group. 288
Individual ion data were also analysed and two m/z values were found to be statistically significant in 289 the ITP group. These were m/z 51 and 69. These m/z values most likely represent methanol, with 290 water hydrates (CH4OH.H + .H2O andCH4OH.H + .2H2O). Table 2 illustrates these data. 291
When propanol data were analysed it can be observed that in the ITP group, the concentration in 292 parts-per-billion (ppb) in urine headspace decreases significantly after E028 diet. Conversely in the 293 control group, although not statistically proven, indicates an opposite pattern where the propanol 294 levels increase after E028 diet ( Figure 5) . 295
Multivariate statistical analysis 296
Due to too few control subjects, the E028 diet data were only analysed for the ITP volunteers. Initial 297 multivariate analysis used data from the H3O + precursor ions. The method showing the best resulting 298 classification was PLS-DA with WTT. This had an overall correct classification of 80% with a specificity 299 of 70% and a sensitivity of 90%. The AUROC was calculated to be 0.9360. Combining the precursor 300 ions as previously described and subjecting to PLS-DA with WTT produced an overall classification 301 (%CC) of 95% (95% specificity and 95% sensitivity). The calculated AUROC was 0.9554. 302
This suggests that the effects of the E028 Extra via SIFT-MS and pattern recognition are very clearly 303 visible, thus demonstrating the effect on urine headspace VOCs following elemental diet. 304
Discussion 305
This study investigated ITP and urine headspace changes in relation to dietary changes and food 306
intolerance. There were no increases in platelet counts when ITP subjects maintained an E028 Extra 307 diet, implying that it was unlikely that ITP is caused by food intolerance. This is in contrast to Crohn's 308 disease, where the E028 extra brings about long term remission of the condition and therefore long 309 term dietary therapy is practicable (21). 310
Although much research has been carried out looking at the effects certain drugs have in causing ITP, 311
it is still unknown if these mechanisms could also explain why some foods may cause similar reactions. 312
However, it has been noted that drug induced reactions can take up to 7 days to appear (22), which 313 would imply a different reaction than foods as these have generally been reported, to occur very 314 rapidly (23). 315
Research looking at actual platelet counts in relation to food intolerance is limited and mostly relate 316 to complementary therapies, supplements and drinks, rather than a full scale look at specific foods 317 (24). It is difficult to know if there have been any other experiences of these type of results when 318 looking at chronic ITP and not just isolated or acute episodes as is often reported as by Royer et al., in 319 2010. It is also unknown if diet or dietary modification has ever been assessed in relation to actual 320 platelet count data. 321
What could be hypothesised is that there are certain groups of people, or certain medical conditions 322 that lead to a person having a predisposition for the way in which they process their food. This is then 323 ultimately influenced by bacteria in the gut and may be related to factors including the type of bacteria 324
in the population, the number of those bacteria and their responses to the food presented to them. 325
Explaining significant m/z values 326
Analysis of the headspace using SIFT-MS showed differences in propanol in ITP compared with healthy 327
subjects, but cannot distinguish between 1-propanol, or 2-propanol. Propanol is a fermentation 328 product in the gut, for example and Hosseini et al in 2011 found that Clostridium neopropionicum X4 329 was able to ferment (1-13 C)-ethanol and CO2 to (2-13 C)-Propanol, suggesting that this compound is 330 potentially produced via fermentation by bacteria. 331
Ions of m/z 18 and 36 most likely correspond to the compound ammonia. Ammonia is ubiquitous in 332 urine due to the fact it is a breakdown product of urea, and as a simple nitrogenous product it is of 333 interest biologically as it can be used by living organisms for protein synthesis (25, 26) . Bacteria can 334 also utilise it for their nitrogen requirements and bacteria can also be major producers of ammonia 335 too (27). Ammonia can be found in many tissues in the body including muscle and kidneys but it also 336 enters the circulation from the gastrointestinal tract. During deamination, significant ammonia is 337 released and endogenously it is also released by the kidney. The third source is formed in the 338 gastrointestinal tract by the action of amino-acid oxidase and urease derived from bacteria (28). The 339 micro-organisms responsible for urease activity include enterobacteria, bacterioides, clostridia and 340
Klebsiellaaerobacter (29). 341
Overall it is extremely difficult to pinpoint exactly why the ammonia levels were significantly different 342 between ITP and healthy controls but again, one of the more likely causes is gut fermentation -343 considerable amounts of ammonia have been shown to be produced by bacteria from non-urea 344 sources. Ammonia has been shown to be a potentially toxic product of protein breakdown in the large 345
intestine and it seems to be a compound that is repeatedly indicated in a number of diseased states 346 (30). Richardson suggests that a functional group on a 'deaminative' bacteria exists, which is similar 347 to the 'hyper-ammonia producing' bacteria in the rumen of cattle and sheep, and that if these exist in 348 the human colon they may have a similar significance with fermentation, and may also be manipulated 349 via dietary modification (30). This repetitive indication of the compound suggests it is not unique to 350 any one disease and therefore would not alone, be useful as an indicator of a specific disease. 351
Add bit here on breakdown of platelets? 352 SIFT-MS analysis following dietary changes proved that the size of the sample groups were too small 353 to offer convincing evidence of potential compounds that may be useful. However, it showed how 354 the counts per second of different m/z values changed before and after the diet. 355
Linking to metabolism and the gut microbiome 356
What multivariate analysis indicated is a metabolic or metabolomic difference in the profiles of ITP 357 sufferers and healthy controls. Multivariate data analysis showed that with a specificity of 87% and a 358 sensitivity of 88%, samples from ITP sufferers can be distinguished from healthy controls with a 359 percentage correctly classified with an accuracy of 88%. This means that the test could correctly 360 differentiate 88% of the samples into either the ITP group or the control group. This is potentially 361 useful due to the fact ITP is a multifactorial disease and so difficult to diagnose. If a method was 362 available to help identify a certain metabolomic pattern in a person to suggest ITP -along with their 363 presenting symptoms -it could help faster and less invasive diagnosis. Aside from the diagnostic 364 possibilities, the differences in the headspace of urine in ITP patients and controls demonstrates a 365 clear metabolic difference in these subjects and this could then lead to a greater understanding of the 366 origin of this debilitating condition. 367
One possibility is that these differences result from changes in gut flora in ITP patients. The 368
'microbiomial relationship' can become imbalanced via various internal and external factors. Evidence 369
suggests that much of this impact is mediated through diet and also suggests that the gut microbes 370
can influence what the human host is able to extract from its diet, including energetically (31). The 371 intestinal microbiome has a high level of metabolic activity and diet, genetic factors, bodily changes 372 (e.g. pregnancy), ageing, environment, chemical therapies and pharmacology can all affect it (32). In 373 turn, the microbiome can have an effect not only on the gut itself but also on the immune response 374
and immune system. 375
These bacteria coexist in a complex mutually beneficial relationship which is physiologically important 376 to host-microbe interactions in the gut in both directions (33). If the bacterial profile changes, it can 377 lead to added issues for the host including possible changes in fermentation in the gut. If the microbial 378 community is maladapted to its environment, it will actually impair all these processes and result in 379 disease states including allergy, obesity, diabetes, rheumatoid arthritis (RA), cancer and inflammatory 380 bowel disease (34). This in turn causes persistent peripheral antigenic stimulation. In genetically susceptible individuals, 384
this antigenic stimulation could result in expression of overt RA via molecular mimicry, a factor which 385
is also thought to play a role in ITP. 386
It is therefore possible that such factors can also be implicated in conditions such as ITP. One case of 387 ITP highlighted was show by Borody et al in 2011. Here a patient had presented with chronic relapsing 388 ulcerative colitis with concomitant ITP. This patient was offered faecal microbiota transplant (FMT) 389
and accepted the offer. The mean platelet count prior to FMT was below 100,000 per µl, following 390 recurrent FMT the platelet count increased to 168,000 per µl then onto a steady progression to a 391 normal range (mean 195,000 per µl, range 153,000-261,000 per µl). They concluded from this 392 'unexpected' side effect of FMT that some cases of ITP should be reassessed as arising from an 393 'infection' in the gut microbiota (35). 394
The findings of this study suggest further research is required into the gut microbiome of ITP patients. 395 With work having been carried out by van der Waaji et al. in 2004 which showed that patients with 396 IBD had an increased percentage of immunoglobulin-coated faecal anaerobic bacteria in both active 397 disease, and just after remission, this area would be extremely pertinent to follow up with in ITP. 398
It is also pertinent to mention the fact the ITP group was compared to a healthy volunteer group. The 399 intent of this was to examine differences and similarities between groups not suggest it is suitable at 400 this point as a diagnostic test. A further study to compare the ITP group to a group with co-related 401 diseases would be beneficial to also show how these metabolomic changes occur in diseased groups 402 and if they follow a similar pattern to the ITP group. 403 5. Acknowledgements 404
